Dendreon Corporation’s Prostate Cancer Vaccine Extends Survival In Eastern Virginia Medical School Study

CHICAGO (AP) -- An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday.

MORE ON THIS TOPIC